| Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells VV Orlova, FE Van Den Hil, S Petrus-Reurer, Y Drabsch, P Ten Dijke, ... Nature protocols 9 (6), 1514-1531, 2014 | 366 | 2014 |
| Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts VV Orlova, Y Drabsch, C Freund, S Petrus-Reurer, FE van den Hil, ... Arteriosclerosis, thrombosis, and vascular biology 34 (1), 177-186, 2014 | 240 | 2014 |
| Differentiation and functional comparison of monocytes and macrophages from hiPSCs with peripheral blood derivatives X Cao, GK Yakala, FE van den Hil, A Cochrane, CL Mummery, VV Orlova Stem cell reports 12 (6), 1282-1297, 2019 | 92 | 2019 |
| Inflammatory responses and barrier function of endothelial cells derived from human induced pluripotent stem cells V Halaidych, C Freund, F van den Hil, DCF Salvatori, M Riminucci, ... Stem Cell Reports 10 (5), 1642-1656, 2018 | 77 | 2018 |
| Scalable microphysiological system to model three-dimensional blood vessels MNS de Graaf, A Cochrane, FE van den Hil, W Buijsman, ... APL bioengineering 3 (2), 2019 | 58 | 2019 |
| Engineered 3D vessel-on-chip using hiPSC-derived endothelial-and vascular smooth muscle cells MV Cuenca, A Cochrane, FE van den Hil, AAF de Vries, SAJL Oberstein, ... Stem cell reports 16 (9), 2159-2168, 2021 | 56 | 2021 |
| Generation and functional characterization of monocytes and macrophages derived from human induced pluripotent stem cells X Cao, FE van den Hil, CL Mummery, VV Orlova Current Protocols in Stem Cell Biology 52 (1), e108, 2020 | 22 | 2020 |
| Quantitative analysis of intracellular Ca2+ release and contraction in hiPSC-derived vascular smooth muscle cells V Halaidych, A Cochrane, FE van den Hil, CL Mummery, VV Orlova Stem Cell Reports 12 (4), 647-656, 2019 | 18 | 2019 |
| Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip VV Orlova, DM Nahon, A Cochrane, X Cao, C Freund, F van den Hil, ... Stem Cell Reports 17 (7), 1536-1545, 2022 | 17 | 2022 |
| Vascular tumor recapitulated in endothelial cells from hiPSCs engineered to express the SERPINE1-FOSB translocation DGP van IJzendoorn, DCF Salvatori, X Cao, F van den Hil, ... Cell Reports Medicine 1 (9), 2020 | 11 | 2020 |
| Microfluidic assay for the assessment of leukocyte adhesion to human induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) V Halaidych, F van den Hil, CL Mummery, VV Orlova JoVE (Journal of Visualized Experiments), e58678, 2018 | 11 | 2018 |
| Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c. 1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia … MJ Bouma, V Orlova, FE van den Hil, HJ Mager, F Baas, P de Knijff, ... Stem Cell Research 46, 101786, 2020 | 5 | 2020 |
| Dynamic inflammatory stimulation of hiPSC-endothelial cells in a multiplexed microfluidic chip AR Vollertsen, K Le, L van den Hil, K Vermeul, B van Meer, ... EUROoCS Annual conference 2021, 2021 | | 2021 |
| Modeling hereditary haemorrhagic telangiectasia (HHT) with patient specific induced pluripotent stem cells (IPSCS) V Orlova, C Freund, L Hil, SP Reurer, L Hawinkels, GS Duffhues, F Disch, ... Angiogenesis 18 (4), 532-532, 2015 | | 2015 |
| Differentiation and functionality of endothelial cells and pericytes from human induced pluripotent stem cells VV Orlova, C Freund, S Petrus-Reurer, FE van den Hil, Y Drabsch, P Dijke, ... Angiogenesis 17 (3), 760-760, 2014 | | 2014 |
